Speech-Language Pathologists in Geneseo, IL Accepting Medicare

5 Speech-Language Pathologists found. Showing 1 - 5

Mrs. Stacie Meri Hatfield, ED.D., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 522 E Exchange St, Geneseo, IL 61254 Phone: 309-269-7594

Emily Izral Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 415 N Russell Ave, Geneseo, IL 61254 Phone: 309-945-0625

Ms. Carly Marie Kupersmith Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 415 N Russell Ave, Geneseo, IL 61254 Phone: 309-945-0625

Margaret Wendell, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 477 Bur Oak Dr, Geneseo, IL 61254 Phone: 309-798-1111

Bridget Real Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 N College Ave, Geneseo, IL 61254 Phone: 309-944-6431

News Archive

GE Capital's Healthcare Financial Services provides $9 million term loan to Cerapedics

GE Capital's Healthcare Financial Services business has provided a $9 million term loan to Cerapedics, Inc., a privately-held medical device company based in Westminster, CO. The funds will be used to support Cerapedics' general business operations, including the advancement of its U.S. regulatory process.

Cytoplasmic HIF-2α linked to poor prognosis in renal cell carcinoma

Cytoplasmic expression of hypoxia inducible factor-2α is associated with poor prognosis in patients with clear cell renal cell carcinoma, study findings indicate.

Lessons learned from troubles with COX-2 inhibitors

One of the nation's leading cardiovascular medical researchers has issued a call for less aggressive direct-to-consumer advertising and better safety assurances of medications in a special article posted online by JAMA because of its relevance to the recent withdrawals and warning labels on the pain-relieving drugs known as COX-2 inhibitors.

Clear link between male subfertility and lower risk of prostate cancer

Involuntary childlessness owing to reduced fertility is a concern for many men. However, these men do have one advantage - they run a significantly lower risk of suffering from prostate cancer. Researchers are interested in whether this phenomenon could be used in the fight against cancer.

LifeNet Health launches the Vertigraft Cervical Bio-Implant with Preservon Technology

LifeNet Health, a leading allograft bio-implant company, announces the launch of Vertigraft Cervical Bio-Implant (VG2C) with Preservon® Technology

Read more Medical News

› Verified 9 days ago